The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

Abstract

In an early assessment, the combination of Campath-1H, low dosing of tacrolimus and mycophenolate mofetil, and avoidance of maintenance corticosteroid use seems to be safe and effective for kidney transplant recipients. Long-term outcomes will be reported in the future.